HEALTHCARE

Joining the EU's digital Covid certificate program will ease travel between Israel and the EU and could renew incoming tourism.

The buyer, ZOLL Medical, is paying a 50% premium over Itamar Medical's share price before the announcement.

Check Point has reported to Israel Police a Telegram group selling fake negative tests to pilgrims returning from Uman.

The District Court in Boston Massachusetts ruled that Teva must face claims under the False Claims Act of defrauding Medicare.

HRA is a fast-growing OTC company, with three category-leading self-care brands in blister care, women's health, and scar care.

Using artificial intelligence, Biolojic Design founder Prof Yanay Ofran believes he can produce antibodies that are a match for any disease.

Lumenis will remain with 1,000 employees in its laser and RF activities and CEO Tzipi Ozer-Armon said it is expanding these activities and already hiring.

The former Israeli prime minister has warrants worth NIS 18 million in the Israeli medical cannabis company.

The US dental implants company has 100 employees at its R&D center in Israel.

The companies are in digital pathology and lung cancer diagnosis.

Waste burning is the source of 62% of the carcinogens released into the air, while Israel is a leader for greenhouse gas emissions per capita.

The Israeli company has developed cartilage implants made from coral.

The company provides pediatric nutritional products that are backed by clinical research and are formulated to nourish children during their different stages of growth.

The rate of seriously ill patients among those with three jabs was 0.008% compared with 0.012% among those with two vaccinations and 0.014% among those who were unvaccinated.

Aesthetic medicine veteran Eckhouse (Lumenis, Syneron) explains what's new about SofWave and why it chose Tel Aviv for a flotation.

Resentment at the high earnings of technology sector employees overlooks their outsize contribution to Israel's economy.

Dr. Yaron Daniely of healthcare VC firm aMoon intends to take an active approach to turning academic research into viable companies.

Having sold all its non-healthcare activities, Philips CEO Frans van Houten tells "Globes" about future plans, with Israel figuring largely.

Legendary medical device investor Lewis Pell talks about what he brings to inventors, breaking up with Shlomo Ben-Haim, and healthcare's future.